Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.066
▾0.001 (1.54%)
Last trade: 01/07, 6:52PM
Market cap
$36.24m
Market closed
Investor Presentations
Principal Activity
Pharmaxis Limited (PXS) is a specialty pharmaceutical company involved in the research, development and commercialisation of therapeutic products for chronic respiratory disorders. PXS has two approved products: Bronchitol for cystic fibrosis and Aridol diagnosis of asthma; and four products in development: PXS-4728, LOX platform technology Orbital, ASM8. Headquartered in Sydney at its Frenchs Forest manufacturing facilities, Pharmaxis also has offices in Europe and the United States. Former Names Pharmaxis Limited PXS (11/11/2003)
Address
2/20 Rodborough Rd, Frenchs Forest NSW 2086, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.066
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Support
Live Chat
Markets
Contact Us
(03) 9661 0441
clients@freshequities.com
Address
Level 16, 452 Flinders St
Melbourne VIC 3000
Australia